Cold agglutinin disease (CAD) is a rare, autoimmune hemolytic anemia in which cold-reacting autoantibodies (cold agglutinins) bind to normal antigens on the surface of red blood cells during passage through the cooler peripheral circulation. These antibodies cause agglutination of red blood cells, leading to an immune response and premature destruction of the healthy red blood cells. The authors have written this resource to give clinicians the information they need to successfully diagnose and manage CAD in adult patients.
Cold agglutinin disease (CAD) is a rare, autoimmune hemolytic anemia in which cold-reacting autoantibodies (cold agglutinins) bind to normal antigens on the surface of red blood cells during passage through the cooler peripheral circulation. These antibodies cause agglutination of red blood cells, leading to an immune response and premature destruction of the healthy red blood cells. The authors have written this resource to give clinicians the information they need to successfully diagnose and manage CAD in adult patients.
You may be unfamiliar with pyruvate kinase (PK) deficiency. It is a rare inherited enzyme disorder that affects the glycolytic pathway used by red blood cells to generate energy, manifesting as hemolytic anemia. The symptoms vary greatly between individuals, making diagnosis difficult, and management primarily comprises supportive treatments. Written by experts in the field, 'Fast Facts: Pyruvate Kinase Deficiency' provides a comprehensive introduction to the condition, including details of: • the underlying defect • its mode of inheritance, and the relationship between genotype and phenotype • how the condition manifests • the fundamentals of diagnosis and how to differentiate it from a heterogeneous group of hemolytic disorders • monitoring and managing the complications that may arise. 'Fast Facts: Pyruvate Kinase Deficiency' will be of interest to primary care providers, hematologists, oncologists, pediatricians, internal medicine specialists, hematology nurses and medical students; indeed, anyone who wishes to learn more about this rare genetic blood disorder. Contents: • Overview • Epidemiology and etiology • Differential diagnosis • Diagnosis of pyruvate kinase deficiency • Complications and monitoring • Supportive treatment
You may be unfamiliar with pyruvate kinase (PK) deficiency. It is a rare inherited enzyme disorder that affects the glycolytic pathway used by red blood cells to generate energy, manifesting as hemolytic anemia. The symptoms vary greatly between individuals, making diagnosis difficult, and management primarily comprises supportive treatments. Written by experts in the field, 'Fast Facts: Pyruvate Kinase Deficiency' provides a comprehensive introduction to the condition, including details of: • the underlying defect • its mode of inheritance, and the relationship between genotype and phenotype • how the condition manifests • the fundamentals of diagnosis and how to differentiate it from a heterogeneous group of hemolytic disorders • monitoring and managing the complications that may arise. 'Fast Facts: Pyruvate Kinase Deficiency' will be of interest to primary care providers, hematologists, oncologists, pediatricians, internal medicine specialists, hematology nurses and medical students; indeed, anyone who wishes to learn more about this rare genetic blood disorder. Contents: • Overview • Epidemiology and etiology • Differential diagnosis • Diagnosis of pyruvate kinase deficiency • Complications and monitoring • Supportive treatment
Cold agglutinin disease (CAD) is a rare, autoimmune hemolytic anemia in which cold-reacting autoantibodies (cold agglutinins) bind to normal antigens on the surface of red blood cells during passage through the cooler peripheral circulation. These antibodies cause agglutination of red blood cells, leading to an immune response and premature destruction of the healthy red blood cells. The authors have written this resource to give clinicians the information they need to successfully diagnose and manage CAD in adult patients.
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.